NeuroPace, Inc.

NeuroPace, Inc.

NPCE · Nasdaq

NeuroPace, Inc. (NPCE) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for NeuroPace, Inc. in 2026. The next earnings report is expected on November 10, 2026.

Earnings calendar

Next earnings date

10 Nov 2026

In 82 days

EPS estimate

-0.12

Revenue estimate

27.1M

Past earnings

11 Aug 2026
EPS actual
-0.18 (+17.4%)
estimate -0.22
Revenue actual
22.8M (+0.9%)
estimate 22.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
-0.13 (+42.6%)
estimate -0.23
Revenue actual
22.0M (+1.6%)
estimate 21.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
03 Mar 2026
EPS actual
-0.08 (+48.8%)
estimate -0.16
Revenue actual
26.6M (+7.4%)
estimate 24.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

NeuroPace beat consensus estimates in its latest earnings report, with EPS of -$0.18 beating the estimate of -$0.2179 and revenue of $22.83 million exceeding estimates by 0.9%. Both EPS and revenue were also ahead of expectations in the previous report.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Sector
Healthcare
Industry
Medical devices
Country
United States
Exchange
Nasdaq
CEO
Joel D. Becker
Employees
184
IPO date
22 Apr 2021
ISIN
US6412881053
Website
neuropace.com

Frequently asked questions

When does NeuroPace, Inc. (NPCE) next report earnings?

NeuroPace, Inc. (NPCE) is scheduled to report earnings on November 10, 2026.

What was NeuroPace, Inc.'s most recent earnings date?

NeuroPace, Inc. (NPCE) last reported earnings on August 11, 2026.

Where is NeuroPace, Inc. stock listed?

NeuroPace, Inc. (NPCE) is listed on Nasdaq.